Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01.10. | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | 1 | ASX | ||
25.09. | VITURA HEALTH LIMITED: Update - Dividend/Distribution - VIT | - | ASX | ||
25.09. | VITURA HEALTH LIMITED: DRP allocation price | - | ASX | ||
VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
24.09. | VITURA HEALTH LIMITED: Date for 2025 AGM | - | ASX | ||
09.09. | VITURA HEALTH LIMITED: Becoming a substantial holder | - | ASX | ||
09.09. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
05.09. | Dividendenbekanntmachungen (05.09.2025) | 12.438 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAON INC US0003602069 0,1 USD 0,0858 EUR ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2017 EUR AIA GROUP LTD HK0000069689 0... ► Artikel lesen | |
27.08. | VITURA HEALTH LIMITED: Investor Webinar and presentation | - | ASX | ||
25.08. | VITURA HEALTH LIMITED: Dividend/Distribution - VIT | - | ASX | ||
25.08. | VITURA HEALTH LIMITED: Declaration of dividend | - | ASX | ||
25.08. | VITURA HEALTH LIMITED: FY2025 Financial Results | - | ASX | ||
25.08. | VITURA HEALTH LIMITED: ASX Appendix 4G Corporate Governance Principles | - | ASX | ||
25.08. | VITURA HEALTH LIMITED: 2025 Financial Report | - | ASX | ||
25.08. | VITURA HEALTH LIMITED: ASX Appendix 4E Preliminary Final Report | - | ASX | ||
04.08. | VITURA HEALTH LIMITED: Notification regarding unquoted securities - VIT | - | ASX | ||
04.08. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
30.07. | VITURA HEALTH LIMITED: Change in largest shareholder | - | ASX | ||
30.07. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
30.07. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
08.07. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 4,565 | -13,87 % | Piramal Pharma Solutions Implements POD Method at Aurora API Facility | ||
TILRAY BRANDS | 1,469 | -18,66 % | Zweistellig gestiegen: Tilray high: Nach den Ergebnissen knallt die Aktie! | © Foto: Dall-ENach einer langen Verlustserie macht Tilray Gewinne. Das gefällt auch den Anlegern. Die Aktie klettert zweistellig.Tilray liefert im ersten Quartal des Geschäftsjahres 2026 ein echtes... ► Artikel lesen | |
ORGANIGRAM GLOBAL | 1,620 | -7,95 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
SNDL | 2,230 | -8,46 % | SNDL Inc.: SNDL Announces 2025 Annual and Special Meeting Results | EDMONTON, AB, July 31, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders... ► Artikel lesen | |
MYDECINE INNOVATIONS GROUP | 0,003 | 0,00 % | Mydecine Innovations Group Inc.: Mydecine Innovations Group Announces Results Of Shareholder Meeting And Provides Corporate Update | ||
BIONANO GENOMICS | 1,950 | -8,88 % | Bionano Genomics: Bionano to Participate in the H.C. Wainwright @ Home Event | ||
TONIX PHARMACEUTICALS | 17,900 | -8,67 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025 | ||
HIGH TIDE | 2,900 | -6,15 % | High Tide hat es das fünfte Jahr in Folge in das Jahresranking des Magazins "Report on Business" der wachstumsstärksten Unternehmen Kanadas geschafft | CALGARY, AB, 26. September 2025 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA) - ein erfolgreiches und
auf den Einzelhandel ausgerichtetes... ► Artikel lesen | |
ACHIEVE LIFE SCIENCES | 2,710 | -4,91 % | ACHIEVE LIFE SCIENCES, INC. - 8-K, Current Report | ||
GREENRISE GLOBAL BRANDS | 0,001 | 0,00 % | Greenrise Global Brands Inc: Greenrise files 2024 results, to file Q1 results | ||
JAGUAR HEALTH | 2,070 | -9,21 % | Jaguar Health, Inc.: Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease | Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support (PS) (comprised of total parenteral... ► Artikel lesen | |
MEDIPHARM LABS | 0,050 | +4,17 % | MediPharm Labs Corp.: MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders | TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids... ► Artikel lesen | |
ARGENT BIOPHARMA | 0,047 | -8,74 % | Argent BioPharma Ltd.: Argent is Growing Through M&A: Projected Merged Company Value of $100M in AC8 Asset Acquisition | Acquisition Expands Clinical Pipeline, Strengthens IP Portfolio, and Grows EU Presence
Highlights
Binding term sheet signed to acquire key assets and IP of AusCann... ► Artikel lesen | |
AUSCANN | - | - | Argent BioPharma Signs $15m Deal to Acquire Key Clinical and IP Assets from AusCann | ||
AYR WELLNESS | 0,048 | 0,00 % | Ayr Wellness Inc.: AYR Wellness Enters Into Restructuring Support Agreement with Senior Noteholders | MIAMI, July 30, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR") together with its affiliates and subsidiaries (collectively the "Company"), a leading vertically integrated... ► Artikel lesen |